Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
Treatment of Neuromyelitis Optica: Review and Recommendations.
Relationship between contrast sensitivity test and disease severity in multiple sclerosis patients.
Contextualized perceptions of movement as a source of expanded insight: People with multiple sclerosis' experience with physiotherapy.
Epidemiologic Study of Charcot-Marie-Tooth Disease: A Systematic Review.
[Changes of epidemiological and clinical features and disease concept in multiple sclerosis].
Review of the novelties from the 2014 ECTRIMS-ACTRIMS Joint Congress, presented at the 7th Post-ECTRIMS Meeting (II).
Silencing of Abcc8 or inhibition of newly upregulated Sur1-Trpm4 reduce inflammation and disease progression in experimental autoimmune encephalomyelitis.
Female sex steroids and glia cells: Impact on multiple sclerosis lesion formation and fine tuning of the local neurodegenerative cellular network.
Cortical excitability changes over time in progressive multiple sclerosis.
Management of fingolimod-associated macular edema.
Induction of intestinal Th17 cells by segmented filamentous bacteria.
On the estimation and correction of bias in local atrophy estimations using example atrophy simulations.
Multiple sclerosis in Syria.
Antibody response against gastrointestinal antigens in demyelinating diseases of the central nervous system.
RORs in Autoimmune Disease.
Fumaric acid esters in psoriasis and multiple sclerosis.
In-silico prediction of drug targets, biological activities, signal pathways and regulating networks of dioscin based on bioinformatics.
Fingolimod Prescribed for the Treatment of Multiple Sclerosis in Patients Younger than Age 18 Years.
Comparative analysis of treatment outcomes in patients with neuromyelitis optica spectrum disorder using multifaceted endpoints.
Multiple sclerosis databases: present and future.
Treatment Adherence and Transitioning Youth in Pediatric Multiple Sclerosis.
High incidence and increasing prevalence of multiple sclerosis in British Columbia, Canada: findings from over two decades (1991-2010).
Sox2 Sustains Recruitment of Oligodendrocyte Progenitor Cells following CNS Demyelination and Primes Them for Differentiation during Remyelination.
Cdk5 regulates developmental remodeling of mushroom body neurons in Drosophila.
Identification of a novel mechanism of action of fingolimod (FTY720) on human effector T cell function through TCF-1 upregulation.
Pages
« first
‹ previous
…
357
358
359
360
361
362
363
364
365
…
next ›
last »